We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
The ExoVasc®️ is designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions. The ExoVasc is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture. Note: This is a Custom-made Medical Device and is not TGA approved.
The new approach: the ExoVasc®️ Personalised External Aortic Root Support – retaining the aorta and valve.
The ExoVasc®️ Personalised External Aortic Root Support provides an alternative to aortic root replacement. A custom-made external support is made to exactly match the patient’s aorta. This is placed around the ascending aorta, which remains intact. Since the vessel and the valve remain intact, the surgery is more straightforward and there is no need for the patient to take anticoagulant drugs.
What is the experience to date?
More than 1,000 patients have already received this external support to their aorta. The first patient received their support over 19 years ago, the total patient experience has now exceeded 3,000 post-operative patient-years, and the ExoVasc®️ support has proven successful in every case in which it has been implanted. In addition to patients with Marfan syndrome, the PEARS operation has been used to treat aortic dilatation in other conditions including Bicuspid Aortic Valve disease and patients with Ehlers-Danlos and Loeys-Dietz syndromes. It has also been successfully used to prevent dilatation in patients undergoing a Ross procedure.
The ExoVasc®️ is designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions. The ExoVasc is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture. Note: This is a Custom-made Medical Device and is not TGA approved.
The new approach: the ExoVasc®️ Personalised External Aortic Root Support – retaining the aorta and valve.
The ExoVasc®️ Personalised External Aortic Root Support provides an alternative to aortic root replacement. A custom-made external support is made to exactly match the patient’s aorta. This is placed around the ascending aorta, which remains intact. Since the vessel and the valve remain intact, the surgery is more straightforward and there is no need for the patient to take anticoagulant drugs.
What is the experience to date?
More than 1,000 patients have already received this external support to their aorta. The first patient received their support over 19 years ago, the total patient experience has now exceeded 3,000 post-operative patient-years, and the ExoVasc®️ support has proven successful in every case in which it has been implanted. In addition to patients with Marfan syndrome, the PEARS operation has been used to treat aortic dilatation in other conditions including Bicuspid Aortic Valve disease and patients with Ehlers-Danlos and Loeys-Dietz syndromes. It has also been successfully used to prevent dilatation in patients undergoing a Ross procedure.
